Medical Imaging Corp
Medical Imaging Corp., through its subsidiaries, provides medical diagnostic imaging services for patients, hospitals and clinics, workers' compensation boards, and insurance companies in North America. It provides remote reading and reporting of medical diagnostic imaging scans. The company also provides magnetic resonance imaging, computed tomography, positron emission tomography, ultrasound, n… Read more
Medical Imaging Corp (MEDD) - Net Assets
Latest net assets as of September 2018: $-7.08 Million USD
Based on the latest financial reports, Medical Imaging Corp (MEDD) has net assets worth $-7.08 Million USD as of September 2018.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.29 Million) and total liabilities ($10.37 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-7.08 Million |
| % of Total Assets | -215.42% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Medical Imaging Corp - Net Assets Trend (2013–2017)
This chart illustrates how Medical Imaging Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Medical Imaging Corp (2013–2017)
The table below shows the annual net assets of Medical Imaging Corp from 2013 to 2017.
| Year | Net Assets | Change |
|---|---|---|
| 2017-12-31 | $-5.33 Million | -84.31% |
| 2016-12-31 | $-2.89 Million | -82.95% |
| 2015-12-31 | $-1.58 Million | -1240.97% |
| 2014-12-31 | $-117.77K | -5099.65% |
| 2013-12-31 | $-2.27K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Medical Imaging Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 626454200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2017)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $33.30K | % |
| Other Comprehensive Income | $184.05K | % |
| Other Components | $2.59 Million | % |
| Total Equity | $-5.33 Million | 100.00% |
Medical Imaging Corp Competitors by Market Cap
The table below lists competitors of Medical Imaging Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Castlecap Capital Inc
V:CSTL-P
|
$3.13K |
|
MTL Cannabis Corp.
F:J4E
|
$3.13K |
|
OROCO RESOURCE (OR6.SG)
STU:OR6
|
$3.13K |
|
GOC Pakistan Ltd
KAR:GOC
|
$3.14K |
|
KLN
WAR:KLN
|
$3.13K |
|
Rebus Holdings Inc.
PINK:RBSH
|
$3.13K |
|
BETA GLASS PLC
XNSA:BETAGLAS
|
$3.12K |
|
HuaAn Zhangjiang Everbright Park
SHG:508000
|
$3.12K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medical Imaging Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2016 to 2017, total equity changed from -2,889,382 to -5,325,459, a change of -2,436,077.
- Net loss of 3,023,024 reduced equity.
- Other comprehensive income increased equity by 45,909.
- Other factors increased equity by 541,038.
Equity Change Factors (2016 to 2017)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.02 Million | -56.77% |
| Other Comprehensive Income | $45.91K | +0.86% |
| Other Changes | $541.04K | +10.16% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Medical Imaging Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $0.00 | $0.00 | x |
| 2015-12-31 | $-0.07 | $0.00 | x |
| 2016-12-31 | $-0.11 | $0.00 | x |
| 2017-12-31 | $-0.18 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medical Imaging Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -41.85%
- • Asset Turnover: 1.72x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 0.00% | -1.28% | 1.70x | 0.00x | $-65.82K |
| 2014 | 0.00% | -3.15% | 0.90x | 0.00x | $-158.34K |
| 2015 | 0.00% | -24.50% | 1.30x | 0.00x | $-1.58 Million |
| 2016 | 0.00% | -18.54% | 1.35x | 0.00x | $-1.04 Million |
| 2017 | 0.00% | -41.85% | 1.72x | 0.00x | $-2.49 Million |
Industry Comparison
This section compares Medical Imaging Corp's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medical Imaging Corp (MEDD) | $-7.08 Million | 0.00% | N/A | $3.13K |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |